Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Total net revenues	$ 1,371.8	$ 1,168.2
Cost of revenues:
Total cost of revenues	600.6	518.8
Gross margin	771.2	649.4
Operating expenses:
Research and development	284.8	248.6
Sales and marketing	303.2	273.3
General and administrative	68.0	60.2
Restructuring (benefits) charges	(0.5)	8.8
Total operating expenses	655.5	590.9
Operating income	115.7	58.5
Other expense, net	(8.6)	(12.9)
Income before income taxes and loss from equity method investment	107.1	45.6
Income tax provision (benefit)	19.6	(10.1)
Loss from equity method investment, net of tax	(2.1)	0.0
Net income	$ 85.4	$ 55.7
Net income per share:
Basic (in dollars per share)	$ 0.26	$ 0.17
Diluted (in dollars per share)	$ 0.26	$ 0.17
Weighted-average shares used to compute net income per share:
Basic (in shares)	322.3	321.8
Diluted (in shares)	329.1	331.1
Product
Total net revenues	$ 912.6	$ 744.3
Cost of revenues:
Total cost of revenues	454.9	378.5
Service
Total net revenues	459.2	423.9
Cost of revenues:
Total cost of revenues	$ 145.7	$ 140.3